Albert Lai, M.D., Ph.D.
Associate Professor In-Residence, Neurology
albertlai@mednet.ucla.edu
310-825-5321
BOX 957334, Neuroscience Research
Building 1, Room 575B
Los Angeles, CA 90095
UNITED STATES
Office Address:
635 Charles E. Young Drive
Los Angeles, CA 90095
UNITED STATES
Publications
- Lai A, Tran A, Nghiemphu PL, Pope WB, Solis OE, Selch M, Filka E, Yong WH, Mischel PS, Liau LM, Phuphanich S, Black K, Peak S, Green RM, Spier CE, Kolevska T, Polikoff J, Fehrenbacher L, Elashoff R, Cloughesy T. Phase II study of bevacizumab plus temozolomide during and after radiation therapy for patients with newly diagnosed glioblastoma multiforme.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010.
- Lai A, Filka E, McGibbon B, Nghiemphu PL, Graham C, Yong WH, Mischel P, Liau LM, Bergsneider M, Pope W, Selch M, Cloughesy T. Phase II pilot study of bevacizumab in combination with temozolomide and regional radiation therapy for up-front treatment of patients with newly diagnosed glioblastoma multiforme: interim analysis of safety and tolerability.. International journal of radiation oncology, biology, physics, 2008.
- Lai A, Le DN, Paznekas WA, Gifford WD, Jabs EW, Charles AC. Oculodentodigital dysplasia connexin43 mutations result in non-functional connexin hemichannels and gap junctions in C6 glioma cells.. Journal of cell science, 2006.